Pharmacom Labs PHARMA Nan D300 is presented in a 10ml vial and reportedly contains 300 milligrams of nandrolone decanoate per milliliter according to the label and packaging. Samples of this product were purchased from a European-based authorized reseller and internet source between the dates of April 10, 2015 and May 10, 2015. The samples were forwarded and received by the analytical laboratory Simec AG for HPLC-UV testing on May 19, 2015. The quantitative dosage testing report was completed on June 2, 2015. The “quality code” listed on the product was “zpgtek35de”. The quality code was successfully used to authenticate/verify the product on /code.
Dienogest was synthesized in 1979 in Jena , Germany under the leadership of Prof. Kurt Ponsold, was initially referred to as STS-557 .   It was found that its potency was 10 times that of levonorgestrel .  The first product on the market to contain dienogest was a combined oral contraceptive pill (with ethinylestradiol), Valette, introduced in 1995 and made by Jenapharm .  In 2007, dienogest was introduced as Dinagest in Japan for the treatment of endometriosis, and it was subsequently marketed for this indication as Visanne in Europe and Australia in December 2009 and April 2010, respectively.  Qlaira was introduced in Europe in 2009 and Natazia was introduced in the United States in 2010. 
The original brand name of oxandrolone was Anavar, which was marketed in the United States and the Netherlands .   This product was eventually discontinued and replaced in the United States with a new product named Oxandrin, which is the sole remaining brand name for oxandrolone in the United States.   Oxandrolone has also been sold under the brand names Antitriol ( Spain ), Anatrophill ( France ), Lipidex ( Brazil ), Lonavar ( Argentina , Australia , Italy ), Protivar, and Vasorome ( Japan ) among others.     Additional brand names exist for products that are manufactured for the steroid black market.